Market Share of Nano Biosensors Industry
The market is neither fragmented nor consolidated since there is no competition between major players. Hence, the market concentration will be moderate. The major players keep on innovating in order to sustain their market share and enter into strategic partnerships.
- September 2020 - Abbott introduced the glucose sport biosensor, called Libre Sense Glucose Sport Biosensor, which is designed for athletes to continuously measure glucose to better understand the correlation between their glucose levels and their athletic performance. The Libre Sense biosensor is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, which was originally developed for people living with diabetes. Based on that technology, this is the first personal-use product that allows for use beyond diabetes.
- Feb 2020 - Researchers of the University of Twente and Wageningen University developed a nanosensor that accurately detects biomarkers for cancer in an extremely broad range of concentrations, from 10 particles per microliter to 1 million particles per microliter. The sensor looks like two combs are woven into each other on the nanoscale, which leaves gaps between the teeth, the electrodes of around 120 nanometres. This small gap size provides amplification of the signal.
- Feb 2019 - The iQ Group Global introduced the Saliva Glucose Biosensor. This innovative technology is one of the world's few non-invasive, saliva-based glucose tests for diabetes management that measures glucose in saliva rather than blood. The saliva-based glucose test is being developed to improve the quality of life for over 425 million people living with diabetes globally.
Nano Biosensors Market Leaders
ACON Laboratories, Inc.
Abbott Point of Care, Inc.
Agilent Technologies, Inc.
Nanowear, Inc.
AerBetic
*Disclaimer: Major Players sorted in no particular order
